STK - Latest News
Columbia Seligman Premium Technology Growth Fund (STK), operates in Financial Services / Asset Management, trades on NYSE.
Market capitalization stands near $970.2M.
The article list below shows the most recent STK headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent STK Headlines
STK Vs. TDVI: The Unicorn CEF And Its Closest ETF Equivalent
seekingalpha.com - Oct 12, 2026
The Columbia Seligman Premium Technology Growth Fund (STK) offers strong total returns, outperforming comparable ETFs like TDVI, and currently trades
Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
businesswire.com - Oct 12, 2026
BEDFORD, Mass. --(BUSINESS WIRE)--Stoke Therapeutics, Inc.
Columbia Seligman Premium Technology Growth Fund Announces a Fourth Quarter Distribution: 9.25% Annual Rate for IPO Investors
businesswire.com - Oct 9, 2026
BOSTON--(BUSINESS WIRE)--Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE: STK) (the Fund) declared a fourth-quarter distribution,
Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
businesswire.com - Oct 6, 2026
BEDFORD, Mass. --(BUSINESS WIRE)--Stoke Therapeutics, Inc.
How To Potentially Retire In Your 40s
seekingalpha.com - Oct 3, 2026
Not everyone wants to or needs to retire early. After all, a 9-5 day job brings steady income, a sense of purpose and discipline, and keeps one engag
Frequently asked STK news questions
- What is the latest STK news headline?
- The most recent STK headline (Oct 12, 2026) is "STK Vs. TDVI: The Unicorn CEF And Its Closest ETF Equivalent". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the STK news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What STK news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual STK options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.